Role of 90K protein in asthma and TH2-type cytokine expression

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 5, 2004, Pages 485-492

  Kalayci, Omer ^a,b   Birben, Esra ^a   Tinari, Nicola ^c   Oguma, Tsuyoshi ^a   Iacobelli, Stefano ^c   Lilly, Craig M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; PROTEIN 90K; UNCLASSIFIED DRUG;

ADULT; ALLERGENICITY; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; SYSTEMIC CIRCULATION; TH2 CELL;

EID: 8644222139     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61417-2     Document Type: Article

References (26)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344:350-362.
2. Kay AB. Allergy and allergic diseases: first of two parts. N Engl J Med. 2001;344:30-37.
3. Kay AB. Allergy and allergic diseases: second of two parts. N Engl J Med. 2001;344:109-113.
4. Hohenester E, Sasaki T, Timpl R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struct Biol. 1999;6:228-232.
5. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem. 1993;268:14245-14249.
6. Fusco O, Querzoli P, Nenci I, et al. 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer. 1998;79:23-26.
7. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S. Mac-2-binding glycoproteins: putative ligands for a cytosolic β-galactoside lectin. J Biol Chem. 1991;266:18731-18736.
8. D'Ostilio N, Sabatino G, Natoli C, Ullrich A, Iacobelli S. 90K (Mac-2 BP) in human milk. Clin Exp Immunol. 1996;104:543-546.
9. Fornarini B, Iacobelli S, Tinari N, Natoli C, de Martino M, Sabatino G. Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol. 1999;115:91-94.
10. Ullrich A, Sures I, D'Egidio M, et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem. 1994;269:18401-18407.
11. Inohara H, Raz A. Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem Biophys Res Commun. 1994;201:1366-1375.
12. Sasaki T, Brakebusch C, Engel J, Timpl R. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998;17:1606-1613.
13. Groschel B, Braner JJ, Funk M, et al. Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol. 2000;20:117-122.
14. Kittl EM, Hofmann J, Hartmann G, et al. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. Clin Chem Lab Med. 2000;38:205-208.
15. Silvestri B, Calderazzo F, Coppola V, et al. Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family. Clin Exp Immunol. 1998;113:394-400.
16. Truong MJ, Gruart V, Liu FT, Prin L, Capron A, Capron M. IgE-binding molecules (Mac-2/εBP) expressed by human eosinophils: implication in IgE-dependent eosinophil cytotoxicity. Eur J Immunol. 1993;23:3230-3235.
17. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051.
18. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309-329.
19. Lilly CM, Nakamura H, Belostotsky OI, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med. 2001;163:1669-1675.
20. Grassadonia A, Tinari N, Iurisci I, et al. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J. 2004;19:551-556.
21. Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods. 1990;132:191-195.
22. Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis. 1987;135:264-267.
23. Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu FT. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the β-galactoside-binding lectin, galectin-3. Am J Pathol. 1996;148:1661-1670.
24. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol. 2001;69:555-564.
25. Wang J, Homer RJ, Chen Q, Elias JA. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol. 2000;165:4051-4061.
26. Powell TJ, Schreck R, McCall M, et al. A tumor-derived protein which provides T-cell costimulation through accessory cell activation. J Immunother Emphasis Tumor Immunol. 1995;17:209-221.